1. 114 Preclinical development of a novel iPSC-derived CAR-MICA/B NK cell immunotherapy to overcome solid tumor escape from NKG2D-mediated mechanisms of recognition and killing. (10th December 2020) Authors: Goulding, John; Pribadi, Mochtar; Blum, Robert; Yeh, Wen-I; Pan, Yijia; Gaidarova, Svetlana; Chang, Chia-Wei; Chu, Hui-Yi; Liu, Ellen; Sikaroodi, Shohreh; Andrade, Lucas Ferrari de; Fong, Lauren; Huffman, Janel; Lee, Tom; Bjordahl, Ryan; Wucherpfennig, Kai; Valamehr, Bahram Journal: Journal for immunotherapy of cancer Issue: Volume 8(2020)Supplement 3 Page Start: A70 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 114 Preclinical development of a novel iPSC-derived CAR-MICA/B NK cell immunotherapy to overcome solid tumor escape from NKG2D-mediated mechanisms of recognition and killing. (9th November 2020) Authors: Goulding, John; Pribadi, Mochtar; Blum, Robert; Yeh, Wen-I; Pan, Yijia; Gaidarova, Svetlana; Chang, Chia-Wei; Chu, Hui-Yi; Liu, Ellen; Sikaroodi, Shohreh; Andrade, Lucas Ferrari de; Fong, Lauren; Huffman, Janel; Lee, Tom; Bjordahl, Ryan; Wucherpfennig, Kai; Valamehr, Bahram Journal: Journal for immunotherapy of cancer Issue: Volume 8(2020)Supplement 3 Page Start: A126 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. 116 Multi-antigen targeting of heterogenous solid tumors using CAR T cells secreting bi-specific T-cell engagers. (10th December 2020) Authors: Hosking, Martin; Shrestha, Bishwas; Boyett, Megan; Shirinbak, Soheila; Gentile, Angela; Sung, Eric; Pan, Yijia; Lee, Tom; ORourke, Jason; Shoemaker, Dan; Nguyen, Cokey; Valamehr, Bahram Journal: Journal for immunotherapy of cancer Issue: Volume 8(2020)Supplement 3 Page Start: A71 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. 116 Multi-antigen targeting of heterogenous solid tumors using CAR T cells secreting bi-specific T-cell engagers. (9th November 2020) Authors: Hosking, Martin; Shrestha, Bishwas; Boyett, Megan; Shirinbak, Soheila; Gentile, Angela; Sung, Eric; Pan, Yijia; Lee, Tom; ORourke, Jason; Shoemaker, Dan; Nguyen, Cokey; Valamehr, Bahram Journal: Journal for immunotherapy of cancer Issue: Volume 8(2020)Supplement 3 Page Start: A128 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. 380 Preliminary results of an ongoing phase I trial of FT500, a first-in-class, off-the-shelf, induced pluripotent stem cell (iPSC) derived natural killer (NK) cell therapy in advanced solid tumors. (9th November 2020) Authors: Hong, David; Patel, Sandip; Patel, Manish; Musni, Kimberly; Anderson, Marlisa; Cooley, Sarah; Valamehr, Bahram; Chu, Wayne Journal: Journal for immunotherapy of cancer Issue: Volume 8(2020)Supplement 3 Page Start: A405 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. 380 Preliminary results of an ongoing phase I trial of FT500, a first-in-class, off-the-shelf, induced pluripotent stem cell (iPSC) derived natural killer (NK) cell therapy in advanced solid tumors. (10th December 2020) Authors: Hong, David; Patel, Sandip; Patel, Manish; Musni, Kimberly; Anderson, Marlisa; Cooley, Sarah; Valamehr, Bahram; Chu, Wayne Journal: Journal for immunotherapy of cancer Issue: Volume 8(2020)Supplement 3 Page Start: A231 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. 470 Targeting Pan-Tumor Associated Antigen B7H3 via Combination of Tri-specific Killer Engager and Off-the-shelf NK Cell Therapy Enhances Specificity and Function Against a Broad Range of Solid Tumors. (9th November 2020) Authors: Miller, Jeffrey; Zorko, Nicholas; Kodal, Behiye; Davis, Zachary; Lenvik, Alexander; Lenvik, Todd; Walker, Joshua; Vallera, Daniel; Gaidarova, Svetlana; Garcia, Alejandro; Lee, Tom; Bjordahl, Ryan; Valamehr, Bahram; Cichocki, Frank; Felices, Martin Journal: Journal for immunotherapy of cancer Issue: Volume 8(2020)Supplement 3 Page Start: A287 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. 470 Targeting Pan-Tumor Associated Antigen B7H3 via Combination of Tri-specific Killer Engager and Off-the-shelf NK Cell Therapy Enhances Specificity and Function Against a Broad Range of Solid Tumors. (9th November 2020) Authors: Miller, Jeffrey; Zorko, Nicholas; Kodal, Behiye; Davis, Zachary; Lenvik, Alexander; Lenvik, Todd; Walker, Joshua; Vallera, Daniel; Gaidarova, Svetlana; Garcia, Alejandro; Lee, Tom; Bjordahl, Ryan; Valamehr, Bahram; Cichocki, Frank; Felices, Martin Journal: Journal for immunotherapy of cancer Issue: Volume 8(2020)Supplement 3 Page Start: A500 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Adaptive single-KIR+NKG2C+ NK cells expanded from select superdonors show potent missing-self reactivity and efficiently control HLA-mismatched acute myeloid leukemia. Issue 11 (1st November 2022) Authors: Haroun-Izquierdo, Alvaro; Vincenti, Marianna; Netskar, Herman; van Ooijen, Hanna; Zhang, Bin; Bendzick, Laura; Kanaya, Minoru; Momayyezi, Pouria; Li, Shuo; Wiiger, Merete Thune; Hoel, Hanna Julie; Krokeide, Silje Zandstra; Kremer, Veronika; Tjonnfjord, Geir; Berggren, Stéphanie; Wikström, Kristin... Journal: Journal for immunotherapy of cancer Issue: Volume 10:Issue 11(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Developing defined culture systems for human pluripotent stem cells. (September 2011) Authors: Valamehr, Bahram; Tsutsui, Hideaki; Ho, Chih-Ming; Wu, Hong Journal: Regenerative medicine Issue: Volume 6:Number 5(2011) Page Start: 623 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗